Dermatology Times, September 2020 (Vol. 41, No. 9)

COVID-19 safety guidelines provide protocols to protect staff, patients

August 27, 2020

Safety guidelines from the European Academy of Facial Plastic Surgery Aesthetic Medicine Focus Group describe protocols for protecting clinic staff and patients from COVID-19. Recommendations include procedures before, during and after a patient visit, as well as necessary forms.

Will OSHA cite me for requesting employees not wear masks?

September 01, 2020

While several employees wanted to wear masks upon his office reopening, Dr. Covid reminded them that their state governor and city mayor did not require their use. Now an employee has contracted COVID-19 from a patient and has filed a complaint with the Occupational Safety and Health Administration. Should he be concerned?

Specialized skincare regimen improves rosacea symptoms

August 14, 2020

Effects of a specialized skincare regimen for sensitive and redness-prone skin were investigated in an eight-week, prospective, controlled clinical trial enrolling 60 patients with rosacea. The intervention was associated with improvements in objectively measured erythema, rosacea symptoms, and health-related quality of life.

Collaboration makes progresses standards for implementing AI

August 11, 2020

The International Skin Imaging Collaboration is an academic and industry partnership designed to facilitate the clinical application of digital skin imaging, with an initial focus on melanoma. The group is developing standards for dermatologic imaging and building a public archive of clinical and dermoscopic images for use in developing artificial intelligence diagnostic algorithms.

Microbiome-based treatments not ready for prime time

August 26, 2020

Manipulating the microbiome has been shown to impact conditions including acne, atopic dermatitis (AD), autoimmune diseases and melanoma. While there are many clinical trials now in progress, safety and efficacy have not yet been proven.

Emerging options for high-risk melanoma

August 26, 2020

Recruiting is ongoing for an investigator-initiated clinical trial of pembrolizumab in clinical stage 2B/C melanoma which will investigate the effects of treatment with pembrolizumab before surgery to remove melanoma on the rate of positive sentinel lymph nodes in patients with stage IIB/C melanoma.

Phenotypes inform management options

August 20, 2020

Many patients with rosacea have features that overlap more than one subtype of the condition. A recent publication serves as a compliment to the classification guide with the intention of guiding treatment and management options based on individual patient features.

How safe are cosmetics?

August 31, 2020

Zoe Diana Draelos, M.D., explains the role of preservatives in skincare products and the general safety and efficacy of products when it comes to protecting the skin against environmental factors.